Stjepan Uldrijan leads the Cancer Biology research group at the Department of Biology, Faculty of Medicine. The group's research centers on molecular mechanisms that regulate cellular signaling pathways driving malignant melanoma. They also investigate how tumor cells respond to stress conditions and are working to identify new targeted therapy options for melanoma. Stjepan Uldrijan was awarded the InGA Accelerate grant in 2022 and 2024 for projects aiming to develop new small-molecule compounds targeting cancer growth.